Neoadjuvant therapy at local versus outside institutions does not adversely impact surgical timing or long-term outcomes in patients with pancreatic adenocarcinoma.
Surgery
; 173(3): 574-580, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36253310
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Adenocarcinoma
Limits:
Humans
Language:
En
Journal:
Surgery
Year:
2023
Document type:
Article
Affiliation country:
India